C. Bourgier

Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study

Thomas Bachelot, C. Bourgier, Claire Cropet et al. · Journal of Clinical Oncology · 2012 · 709 citations · Full text

Medicine, Oncology, Pharmacology +17

Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome

S. Heymann, Suzette Delaloge, Arslane Skander Rahal et al. · Radiation Oncology · 2010 · 208 citations · Full text

Medicine, Oncology, Pathology +17

ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer

Orit Kaidar‐Person, Birgitte Vrou Offersen, S. Hol et al. · Radiotherapy and Oncology · 2019 · 137 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Pravastatin Inhibits the Rho/CCN2/Extracellular Matrix Cascade in Human Fibrosis Explants and Improves Radiation-Induced Intestinal Fibrosis in Rats

Valérie Haydont, C. Bourgier, Marc Pocard et al. · Clinical Cancer Research · 2007 · 136 citations

Medicine, Pathology, Pharmacology +17

Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity

Adeline Granzotto, Mohamed Amine Benadjaoud, Guillaume Vogin et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 122 citations

Medicine, Molecular Biology, Oncology +17